The SA Journal Diabetes & Vascular Disease Vol 15 No 1 (July 2018)

24 / 44

RESEARCH ARTICLE SA JOURNAL OF DIABETES & VASCULAR DISEASE
22 VOLUME 15 NUMBER 1 • JULY 2018
9. Kroll M, Phalkey RK, Kraas F. Challenges to the surveillance of non- communicable
diseases – a review of selected approaches. BMC Public Health 2015; 15: 1243.
doi: 10.1186/s12889-015-2570-z.
10. Dalal S, Beunza JJ, Volmink J, et al. Non-communicable diseases in sub- Saharan
Africa: what we know now. Int J Epidemiol 2011; 40: 885–901. doi: 10.1093/
ije/dyr050.
11. World Health Organization. The STEPS Instrument and Support Materials .
Available from: [Accessed
November 20, 2016].
12. GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and
national life expectancy, all-cause mortality, and cause-specific mortality for
249 causes of death, 1980–2015: a systematic analysis for the Global Burden
of Disease Study 2015. Lancet 2016; 388: 1459–544. doi: 10.1016/S0140-
6736(16)31012-1.
13. World Health Organization. Noncommunicable Diseases Country Profiles
2014. Geneva: World Health Organization, 2014.
14. Simão M, Hayashida M, Santos CB, et al. Hypertension among under- graduate
students from Lubango, Angola. Rev Latino-am Enfermagem 2008; 16(4): 672–
678.
15. Capingana DP, Magalhães P, Silva ABT, et al. Prevalence of cardiovascular risk
factors and socioeconomic level among public-sector workers in Angola. BMC
Public Health 2013; 13: 732. doi: 10.1186/1471-2458- 13-732.
16. Pires JE, Sebastião YV, Langa AJ, et al . Hypertension in Northern Angola:
prevalence, associated factors, awareness, treatment and control. B MC Public
Health 2013; 13: 90. doi: 10.1186/1471-2458-13-90.
17. Evaristo-Neto AD, Foss-Freitas MC, Foss, MC. Prevalence of diabe- tes mellitus
and impaired glucose tolerance in a rural community of Angola. Diabetol Metab
Syndr 2010; 2: 63. doi: 10.1186/1758-5996-2-63.
18. Costa MJ, Rosário E, Langa AJ, et al. Setting up a demographic surveil- lance
system in northern Angola. Afr Pop Stud J 2012; 26: 2.
19. Pedro JM, Rosario E, Brito M, et al. CardioBengo Study Protocol: a population
based cardiovascular longitudinal study in Bengo Province, Angola. BMC Public
Health 2016; 16: 206. 10.1186/s12889-016-2759-9.
20. World Health Organization. Obesity: preventing and managing the global
epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser
2000; 894: 1–253.
21. World Health Organization. Waist circumference and waist–hip ratio: Report of
a WHO Expert Consultation, 2008. Geneva: World Health Organization, 2008.
22. Weber MA, Schiffrinb EL, Whitec WB, et al. Clinical practice guidelines for the
management of hypertension in the community – a statement by the American
Society of Hypertension and the International Society of Hypertension. J Clin
Hypertens (Greenwich) 2014; 16(1): 14–26. doi: 10.1111/jch.12237.
23. World Health Organization. Definition and diagnosis of diabetes mellitus and
intermediate hyperglycaemia: report of a WHO/IDF consultation. Geneva: World
Health Organization, 2006.
24. Guwatudde D, Nankya-Mutyoba J, Kalyesubula R, et al. The burden of
hypertension in sub-Saharan Africa: a four-country cross sectional study. BMC
Public Health 2015; 15: 1211. doi: 10.1186/s12889-015-2546-z.
25. Mensah, GA. Descriptive epidemiology of cardiovascular risk factors and diabetes
in sub-Saharan Africa. Prog Cardiovasc Dis 2013; 56(3): 240–250. doi: 10.1016/j.
pcad.2013.10.014.
26. World Health Organization. STEPS Country Reports . Available from: http://www.
who.int/chp/steps/reports/en/. [Accessed November 20, 2016].
27. NCD Risk Factor Collaboration. Worldwide trends in diabetes since 1980: a
pooled analysis of 751 population-based studies with 4.4 million participants.
Lancet 2016; 387: 1513–1530. doi: 10.1016/S0140-6736(16)00618-8.
28. Popkin BM, Adair LS, Ng SW. Now and then: the global nutrition transition: the
pandemic of obesity in developing countries. Nutr Rev 2012; 70(1): 3–21. doi:
10.1111/j.1753-4887.2011.00456.x.
29. N Mbanya JC, Motala AA, Sobngwi E, et al. Diabetes in sub- Saharan Africa.
Lancet 2010; 375: 2254–2266. doi: 10.1016/S0140-6736(10)60550-8.
30. Hall V, Thomsen RW, Henriksen O, et al. Diabetes in sub-Saharan Africa 1999–
2011: Epidemiology and public health implications. A systematic review. BMC
Public Health 2011; 11: 564. doi: 10.1186/1471-2458-11-564.
31. Hilawe EH, Yatsuya H, Kawaguchia L, et al. Differences by sex in the prevalence
of diabetes mellitus, impaired fasting glycaemia and impaired glucose tolerance
in sub-Saharan Africa: a systematic review and meta- analysis. Bull World Health
Organ 2013; 91: 671–682D. doi: 10.2471/ BLT.12.113415.
32. Adeloye D, Basquill C. Estimating the prevalence and awareness rates of
hypertension in Africa: a systematic analysis. PLoS ONE 2014; 9(8): e104300. doi:
10.1371/journal.pone.0104300.
33. Kayima J, Wanyenze RK, Katamba A, et al. Hypertension awareness, treatment
and control in Africa: a systematic review. BMC Cardiovasc Disord 2013; 13: 54.
doi: 10.1186/1471-2261-13-54.
34. Pereira M, Lunet N, Azevedo A, et al. Differences in prevalence, awareness,
treatment and control of hypertension between developing and developed
countries. J Hypertens 2009; 27: 963–975.
35. Independent Task Force on Noncommunicable Diseases. The emerging global
health crisis: noncommunicable diseases in low and middle-income countries.
Independent Task Force report no 72. New York: Council on Foreign Relations
Press, 2014.
36. Manne-Goehler J, Atun R, Stokes A, et al. Diabetes diagnosis and care in sub-
Saharan Africa: pooled analysis of individual data from 12 countries. Lancet
Diabetes Endocrinol 2016. doi: 10.1016/S2213-8587(16)30181-4.